-+ 0.00%
-+ 0.00%
-+ 0.00%

Leerink Partners Maintains Market Perform on Sarepta Therapeutics, Raises Price Target to $15

Benzinga·09/09/2025 14:08:01
Listen to the news
Leerink Partners analyst Joseph Schwartz maintains Sarepta Therapeutics (NASDAQ:SRPT) with a Market Perform and raises the price target from $12 to $15.